Determinants of glycaemic control in type 2 diabetes African patients monitored by physicians from 1991 to 2004 in Cote d'Ivoire

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 104, Issue 4, 2010, Pages 298-303

  Oga, Serge S A ^a,b   Lokrou, Adrien ^c   Tebi, Ambroise ^a   Malan, Anglade K ^b   Papoz, Laure ^d   Kouadio, Luc P ^b  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE   (Côte d’Ivoire)

^b UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

^d INSERM   (France)

Author keywords

African; C te d'Ivoire; Diabetes mellitus; Glucose; Glycaemia; Outpatient

Indexed keywords

INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; COTE D'IVOIRE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT MONITORING; PHYSICIAN; SEX DIFFERENCE;

ADULT; AGED; BLOOD GLUCOSE; COTE D'IVOIRE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77649180332     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2009.10.011     Document Type: Article

References (21)

1. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
2. Unwin N., Setel P., Rashid S., Mugusi F., Mbanya J.C., Kitange H., et al. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda?. Bull World Health Organ 79 (2001) 947-953
3. Selvin E., Coresh J., Golden S.H., Brancati F.L., Folsom A.R., and Steffes M.W. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 165 (2005) 1910-1916
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53.
5. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28 (1995) 103-117
6. Otieno C.F., Kariuki M., and Ng'ang'a L. Quality of glycaemic control in ambulatory diabetics at the out-patient clinic of Kenyatta National Hospital. Nairobi. East Afr Med J 80 (2003) 406-410
7. Adams A.S., Zhang F., Mah C., Grant R.W., Kleinman K., Meigs J.B., et al. Race differences in long-term diabetes management in an HMO. Diabetes Care 28 (2005) 2844-2849
8. Adebisi S.A., Oghagbon E.K., and Jimoh A.K. Glycated haemoglobin and associated variables in diabetics: Ilorin experience. West Afr J Med 22 (2003) 318-320
9. Gebre-Yohannes A., and Rahlenbeck S.I. Glycaemic control and its determinants in diabetic patients in Ethiopia. Diabetes Res Clin Pract 35 (1997) 129-134
10. Oga A.S., Tebi A., Aka J., Adouéni K.V., Malan K.A., Kouadio L.P., et al. Diabetes in Ivory Coast: special epidemiological features [in French]. Med Trop (Mars) 66 (2006) 241-246
11. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consulatation. Geneva: World Health Organization, 2000, Technical Report Series No. 894.
12. Hosmer W.D., and Lemeshow S. Applied logistic regression. 2nd ed. (2004), John Wiley & Sons, Inc, New York
13. Lokrou A. Etiopathogénie des diabètes sucrés: acquisitions récentes. Rev Franç Endocrinol Clin 27 (1986) 227-237
14. Sobngwi E., Mauvais-Jarvis F., Vexiau P., Mbanya J.C., and Gautier J.F. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab 27 (2001) 628-634
15. Turner R.C., Cull C.A., Frighi V., and Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281 (1999) 2005-2012
16. Otieno F.C., Ng'ang'a L., and Kariuki M. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital. East Afr Med J 79 (2002) 491-495
17. Bonora E. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives. Int J Clin Pract Suppl (2002) 5-11
18. Standl E., Maxeiner S., Raptis S., Karimi-Anderesi Z., and Schweitzer M.A. Good glycemic control with flexibility in timing of basal insulin supply: a 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride. Diabetes Care 28 (2005) 419-420
19. Lester F.T. Insulin therapy: problems in an African country. Diabet Med 2 (1985) 405-407
20. van Zyl D.G., and Rheeder P. Physician education programme improves quality of diabetes care. S Afr Med J 94 (2004) 455-459
21. Oli J.M., Adeyemo A.A., Okafor G.O., Ofoegbu E.N., Onyenekwe B., Chukwuka C.J., et al. Beta cell function and response to treatment in Nigerians with type 2 diabetes mellitus. Diabetes Res Clin Pract 69 (2005) 196-204